449 related articles for article (PubMed ID: 27358229)
1. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
2. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M
Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
Tang Z; Yang Y; Wang X; Meng W; Li X
BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
[TBL] [Abstract][Full Text] [Related]
4. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
Matsuda A; Kuno A; Matsuzaki H; Kawamoto T; Shikanai T; Nakanuma Y; Yamamoto M; Ohkohchi N; Ikehara Y; Shoda J; Hirabayashi J; Narimatsu H
J Proteomics; 2013 Jun; 85():1-11. PubMed ID: 23612463
[TBL] [Abstract][Full Text] [Related]
5. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
Matsuda A; Kuno A; Kawamoto T; Matsuzaki H; Irimura T; Ikehara Y; Zen Y; Nakanuma Y; Yamamoto M; Ohkohchi N; Shoda J; Hirabayashi J; Narimatsu H
Hepatology; 2010 Jul; 52(1):174-82. PubMed ID: 20578261
[TBL] [Abstract][Full Text] [Related]
6. Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.
Tamaki N; Kuno A; Matsuda A; Tsujikawa H; Yamazaki K; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Korenaga M; Mizokami M; Kurosaki M; Sakamoto M; Narimatsu H; Izumi N
Sci Rep; 2017 Mar; 7(1):244. PubMed ID: 28325920
[TBL] [Abstract][Full Text] [Related]
7. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Leelawat K; Sakchinabut S; Narong S; Wannaprasert J
BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942
[TBL] [Abstract][Full Text] [Related]
8. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
9. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
[TBL] [Abstract][Full Text] [Related]
10. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
11. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract][Full Text] [Related]
12. Lectin Microarray-Based Sero-Biomarker Verification Targeting Aberrant O-Linked Glycosylation on Mucin 1.
Matsuda A; Kuno A; Nakagawa T; Ikehara Y; Irimura T; Yamamoto M; Nakanuma Y; Miyoshi E; Nakamori S; Nakanishi H; Viwatthanasittiphong C; Srivatanakul P; Miwa M; Shoda J; Narimatsu H
Anal Chem; 2015 Jul; 87(14):7274-81. PubMed ID: 26091356
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M
J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
Fujiyoshi M; Kuno A; Gotoh M; Fukai M; Yokoo H; Kamachi H; Kamiyama T; Korenaga M; Mizokami M; Narimatsu H; Taketomi A;
J Gastroenterol; 2015 Nov; 50(11):1134-44. PubMed ID: 25773774
[TBL] [Abstract][Full Text] [Related]
15. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
[TBL] [Abstract][Full Text] [Related]
16. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
Koopmann J; Thuluvath PJ; Zahurak ML; Kristiansen TZ; Pandey A; Schulick R; Argani P; Hidalgo M; Iacobelli S; Goggins M; Maitra A
Cancer; 2004 Oct; 101(7):1609-15. PubMed ID: 15378479
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
18. N-glycan structures of Wisteria floribunda agglutinin-positive Mac2 binding protein in the serum of patients with liver fibrosis†.
Noro E; Matsuda A; Kyoutou T; Sato T; Tomioka A; Nagai M; Sogabe M; Tsuruno C; Takahama Y; Kuno A; Tanaka Y; Kaji H; Narimatsu H
Glycobiology; 2021 Nov; 31(10):1268-1278. PubMed ID: 34192302
[TBL] [Abstract][Full Text] [Related]
19. A novel glycobiomarker, Wisteria floribunda agglutinin macrophage colony-stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis.
Iio E; Ocho M; Togayachi A; Nojima M; Kuno A; Ikehara Y; Hasegawa I; Yatsuhashi H; Yamasaki K; Shimada N; Ide T; Shinkai N; Nojiri S; Fujiwara K; Joh T; Mizokami M; Narimatsu H; Tanaka Y
Int J Cancer; 2016 Mar; 138(6):1462-71. PubMed ID: 26437001
[TBL] [Abstract][Full Text] [Related]
20. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
